RMD: 10-K financial filing

rmd-20260630 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________________________________________________ FORM 10-K ___________________________________________________________________________________________ [ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30 , 2026 Commission file number: 001-15317 ___________________________________________________________________________________________ ResMed Inc. (Exact name of registrant as specified in its charter) ___________________________________________________________________________________________ Delaware (State or other jurisdiction of incorporation or organization) 98-0152841 (IRS Employer Identification No.) 9001 Spectrum Center Blvd. San Diego , CA 92123 United States of America (Address of principal executive offices, including zip code) ( 858 ) 836-5000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.004 per share RMD New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act None ___________________________________________________________________________________________ Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No ¨ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ¨ No x Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 duri